CLINICAL RELEVANCE OF BASELINE/EARLY DETECTION AND PERSISTENCE OF RESISTANT ASSOCIATED VARIANTS IN HCV-1 PATIENTS TREATED WITH PROTEASE-INHIBITORS ASSESSED BY ULTRA-DEEP SEQUENCING

Di Maio VC;Armenia D;Bellocchi MC;Di Paolo D;Cento V;Tontodonati M;Micheli V;Carioti L;De Leonardis F;Aragri M;Polilli E;Manunta A;Magni C;Antonucci FP;De Luca F;Sarrecchia C;Bertoli A;Lenci I;Francioso S;Santoro MM;Vecchiet J;De Maria A;Picciotto A;Nosotti L;Morisco F;Bruno S;Puoti M;Babudieri S;Mura MS;Taliani G;Andreoni M;Rizzardini G;Parruti G;Angelico M;Perno CF;Ceccherini-Silberstein F

2015-01-01